Cited by 693Advanced Drug Delivery SystemsRetinal Diseases and TreatmentsOcular Infections and Treatments

The DOI matches its Crossref record; 476 of the 476 references it cites were found in a registry or an index.

Pharmacokinetic aspects of retinal drug delivery

Open access

del Amo, Eva M., Rimpelä, Anna-Kaisa, Heikkinen, Emma, Kari, Otto K., Ramsay, Eva, Lajunen, Tatu, Schmitt, Mechthild, Pelkonen, Laura, Bhattacharya, Madhushree, Richardson, Dominique, Subrizi, Astrid, Turunen, Tiina, Reinisalo, Mika, Itkonen, Jaakko, Toropainen, Elisa, Casteleijn, Marco, Kidron, Heidi, Antopolsky, Maxim, Vellonen, Kati-Sisko, Ruponen, Marika, Urtti, Arto·2017·Progress in Retinal and Eye Research

DOI 10.1016/j.preteyeres.2016.12.001

Open this paper in CoChat — free account Open PDF

Abstract

Drug delivery to the posterior eye segment is an important challenge in ophthalmology, because many diseases affect the retina and choroid leading to impaired vision or blindness. Currently, intravitreal injections are the method of choice to administer drugs to the retina, but this approach is applicable only in selected cases (e.g. anti-VEGF antibodies and soluble receptors). There are two basic approaches that can be adopted to improve retinal drug delivery: prolonged and/or retina targeted delivery of intravitreal drugs and use of other routes of drug administration, such as periocular, suprachoroidal, sub-retinal, systemic, or topical. Properties of the administration route, drug and delivery system determine the efficacy and safety of these approaches. Pharmacokinetic and pharmacodynamic factors determine the required dosing rates and doses that are needed for drug action. In addition, tolerability factors limit the use of many materials in ocular drug delivery. This review article provides a critical discussion of retinal drug delivery, particularly from the pharmacokinetic point of view. This article does not include an extensive review of drug delivery technologies, because they have already been reviewed several times recently. Instead, we aim to provide a systematic and quantitative view on the pharmacokinetic factors in drug delivery to the posterior eye segment. This review is based on the literature and unpublished data from the authors' laboratory.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.preteyeres.2016.12.001

Cites

476 of 476 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Understanding biophysicochemical interactions at the nano–bio interface
Nel, A. E., Mädler, L., Velegol, D., Xia, T., Hoek, E. M. V., Somasundaran, P., Klaessig, F., Castranova, V., & Thompson, M. (2009) · Nature Materials · doi:10.1038/nmat2442 · Cited by 7,083
A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.
Boussif, O., Lezoualc’h, F., Zanta, M. A., Djavaheri‐Mergny, M., Scherman, D., DEMENEIX, B. A., & Behr, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,256
Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis
Wong, W. L., Su, X., Li, X., Cheung, C. M. G., Klein, R., Cheng, C., & Wong, T. Y. (2014) · The Lancet Global Health · doi:10.1016/s2214-109x(13)70145-1 · Cited by 5,545
Regulated portals of entry into the cell
Conner, S. D., & Schmid, S. L. (2003) · Nature · doi:10.1038/nature01451 · Cited by 3,958
Microglia: Active sensor and versatile effector cells in the normal and pathologic brain
Hanisch, U.-K., & Kettenmann, H. (2007) · Nature Neuroscience · doi:10.1038/nn1997 · Cited by 3,676
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Knop, K., Hoogenboom, R., Fischer, D., & Schubert, U. S. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200902672 · Cited by 3,533
The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting
Maeda, H. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00013-3 · Cited by 2,495
Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology
Tenzer, S., Docter, D., Kuharev, J., Musyanovych, A., Fetz, V., Hecht, R., Schlenk, F., Fischer, D., Kiouptsi, K., Reinhardt, C., et al. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2013.181 · Cited by 2,283
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802315 · Cited by 2,145

Show all 476 references

Research works printed but not linked: 7

Barza, 1982, The effects of infection and probenecid on the transport of carbenicillin from the rabbit vitreous humor. Investig. Ophthalmol, Vis. Sci., 22, 720
Gisladottir, 2009, Diffusion characteristics of vitreous humour and saline solution follow the Stokes Einstein equation. Graefe's Arch. Clin. Exp, Ophthalmol, 247, 1677
Haselton, 1996, Modulation of retinal endothelial barrier in a perfused cell-column model of the retinal microvasculature, Investig. Ophthalmol. Vis. Sci., 37, 211
Johnson, 1984, vol. 39, 791
Szebeni, 2005, Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity, Toxicology, 216, 106, 10.1016/j.tox.2005.07.023 · DOI
Szebeni, 2011, Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: prediction and prevention, Adv. Drug Deliv. Rev., 63, 1020, 10.1016/j.addr.2011.06.017 · DOI
U.S. Food and Drug Administration, 2013, Guidance for industry: immunogenicity assessment for therapeutic protein products, Biotechnol. Law Rep., 172

Sorted by citations

Next generation antibody drugs: pursuit of the 'high-hanging fruit'
Carter, P. J., & Lazar, G. A. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.227 · Cited by 780
Mechanisms of mitochondrial dysfunction and their impact on age-related macular degeneration
Kaarniranta, K., Uusitalo, H. M. T., Błasiak, J., Felszeghy, S., Kannan, R., Kauppinen, A., Salminen, A., Sinha, D., & Ferrington, D. A. (2020) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100858 · Cited by 548
Drug Delivery to the Posterior Segment of the Eye: Biopharmaceutic and Pharmacokinetic Considerations
Varela‐Fernández, R., Díaz-Tomé, V., Luaces-Rodríguez, A., Conde-Penedo, A., García‐Otero, X., Álvarez, A. L., Fernández‐Ferreiro, A., & Otero-Espinar, F. J. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12030269 · Cited by 374
Incomplete response to Anti-VEGF therapy in neovascular AMD: Exploring disease mechanisms and therapeutic opportunities
Mettu, P. S., Allingham, M. J., & Cousins, S. W. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100906 · Cited by 370
Diabetic Macular Edema: Current Understanding, Molecular Mechanisms and Therapeutic Implications
Zhang, J., Zhang, J., Zhang, J., Zhang, J., Gu, L., Luo, D., & Qiu, Q. (2022) · Cells · doi:10.3390/cells11213362 · Cited by 325
Nanotechnology-based ocular drug delivery systems: recent advances and future prospects
Li, S., Chen, L., & Fu, Y. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01992-2 · Cited by 323
Design principles of ocular drug delivery systems: importance of drug payload, release rate, and material properties
Subrizi, A., del Amo, E. M., Korzhikov-Vlakh, V. A., Tennikova, T. B., Ruponen, M., & Urtti, A. O. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.02.001 · Cited by 240
Self-citation
Conservative management of retinoblastoma: Challenging orthodoxy without compromising the state of metastatic grace. “Alive, with good vision and no comorbidity”
Munier, F. L., Popovic, M. B., Chantada, G. L., Cobrinik, D. E., Kivelä, T., Lohmann, D. R., Maeder, P. P., Moll, A. C., Carcaboso, A. M., Moulin, A., et al. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.05.005 · Cited by 214
Overcoming negatively charged tissue barriers: Drug delivery using cationic peptides and proteins
Vedadghavami, A., Zhang, C., & Bajpayee, A. G. (2020) · Nano Today · doi:10.1016/j.nantod.2020.100898 · Cited by 217
Principles of pharmacology in the eye
Awwad, S., Mohamed Ahmed, A. H. A., Sharma, G., Heng, J. S., Khaw, P. T., Brocchini, S., & Lockwood, A. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14024 · Cited by 224
Ocular Drug Delivery to the Retina: Current Innovations and Future Perspectives
Kim, H. M., & Woo, S. J. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13010108 · Cited by 198
Hyaluronic acid in ocular drug delivery
Zhang, X., Wei, D., Xu, Y., & Zhu, Q. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.118006 · Cited by 196
The effects of PEGylation on LNP based mRNA delivery to the eye
Ryals, R. C., Patel, S., Acosta, C., McKinney, M., Pennesi, M. E., & Sahay, G. (2020) · PLOS ONE · doi:10.1371/journal.pone.0241006 · Cited by 194
Poloxamer-based in situ gelling thermoresponsive systems for ocular drug delivery applications
Soliman, K., Ullah, K., Shah, A., Jones, D. S., & Singh, T. R. R. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.05.036 · Cited by 190
New concepts in the diagnosis and management of choroidal metastases
Mathis, T., Jardel, P., Loria, O., Delaunay, B., Nguyen, A.-M., Lanza, F. B., Mosci, C., Caujolle, J., Kodjikian, L., & Thariat, J. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.09.003 · Cited by 174
Exploring the Impact of Morphology on the Properties of Biodegradable Nanoparticles and Their Diffusion in Complex Biological Medium
Ridolfo, R., Tavakoli, S., Junnuthula, V., Williams, D. S., Urtti, A. O., & van Hest, J. C. M. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.0c00726 · Cited by 177
Self-citation
Lipid Nanoparticles as a Promising Drug Delivery Carrier for Topical Ocular Therapy—An Overview on Recent Advances
Jacob, S., Nair, A. B., Shah, J., Gupta, S., Boddu, S. H. S., Sreeharsha, N., Joseph, A., Shinu, P., & Morsy, M. A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030533 · Cited by 164
Intravitreal hydrogels for sustained release of therapeutic proteins
Ilochonwu, B. C., Urtti, A. O., Hennink, W. E., & Vermonden, T. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.07.031 · Cited by 160
Self-citation
Polysaccharides in Ocular Drug Delivery
Dubashynskaya, N. V., Poshina, D. N., Raik, S. V., Urtti, A. O., & Skorik, Y. А. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics12010022 · Cited by 150
Self-citation
Pharmacokinetics of Intravitreal Anti-VEGF Drugs in Age-Related Macular Degeneration
García‐Quintanilla, L., Luaces-Rodríguez, A., Gil‐Martínez, M., Mondelo‐García, C., Maroñas, O., Sanjuan, V. M., González‐Barcia, M., Zarra‐Ferro, I., Aguiar, P., Otero-Espinar, F. J., et al. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11080365 · Cited by 151
Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutations
Dulla, K., Slijkerman, R. W. N., van Diepen, H. C., Albert, S., Dona, M., Beumer, W., Turunen, J. J., Chan, H. L., Schulkens, I. A. E., Vorthoren, L., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.04.024 · Cited by 147
Overview of Recent Advances in Nano-Based Ocular Drug Delivery
Liu, L.-C., Chen, Y., & Lu, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015352 · Cited by 152
Target strategies for drug delivery bypassing ocular barriers
Suri, R., Beg, S., & Kohli, K. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.101389 · Cited by 134
Innovations in Nanoemulsion Technology: Enhancing Drug Delivery for Oral, Parenteral, and Ophthalmic Applications
Jacob, S., Kather, F. S., Boddu, S. H. S., Shah, J., & Nair, A. B. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16101333 · Cited by 131
Drug Delivery Systems in Regenerative Medicine: An Updated Review
Mansour, A., Romani, M., Acharya, A. B., Rahman, B., Verron, É., & Badran, Z. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020695 · Cited by 138
Ocular drug delivery targeted by iontophoresis in the suprachoroidal space using a microneedle
Jung, J. H., Chiang, B., Grossniklaus, H. E., & Prausnitz, M. R. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.03.001 · Cited by 131
Challenges and opportunities for drug delivery to the posterior of the eye
Cabrera, F. J., Wang, D. C., Reddy, K., Acharya, G. S., & Shin, C. S. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.05.035 · Cited by 123
Ocular barriers to retinal delivery of intravitreal liposomes: Impact of vitreoretinal interface
Tavakoli, S., Peynshaert, K., Lajunen, T., Devoldere, J., del Amo, E. M., Ruponen, M., Smedt, S. C. D., Remaut, K., & Urtti, A. O. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.10.028 · Cited by 122
Self-citation
Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01
Pascual-Pasto, G., Bazan-Peregrino, M., Olaciregui, N. G., Restrepo-Perdomo, C. A., Mato-Berciano, A., Ottaviani, D., Weber, K., Correa, G., Paco, S., Vila-Ubach, M., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aat9321 · Cited by 118
Topical Drug Delivery to the Posterior Segment of the Eye
Löscher, M., Seiz, C., Hurst, J., & Schnichels, S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14010134 · Cited by 111
Revisiting systemic treatment of bacterial endophthalmitis: a review of intravitreal penetration of systemic antibiotics
Brockhaus, L., Goldblum, D., Eggenschwiler, L., Zimmerli, S., & Marzolini, C. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.01.017 · Cited by 108
Nano-based eye drop: Topical and noninvasive therapy for ocular diseases
Wang, C., & Pang, Y. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114721 · Cited by 109
Polymer based sustained drug delivery to the ocular posterior segment: barriers and future opportunities for the treatment of neovascular pathologies
Alshaikh, R. A., Waeber, C., & Ryan, K. B. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114342 · Cited by 110
Subretinal injection techniques for retinal disease: A review
Irigoyen, C., Amenabar Alonso, A., Sanchez-Molina, J., Rodríguez-Hidalgo, M., Lara-López, A., & Ruiz-Ederra, J. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11164717 · Cited by 106
Diabetic Retinopathy in the Aging Population: A Perspective of Pathogenesis and Treatment
Leley, S. P., Ciulla, T. A., & Bhatwadekar, A. D. (2021) · Clinical Interventions in Aging · doi:10.2147/cia.s297494 · Cited by 100
Application of Nanotechnology in the COVID-19 Pandemic
Yang, D. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s296383 · Cited by 99
Topical drug delivery devices: A review
Bertens, C. J. F., Gijs, M., van den Biggelaar, F. J. H. M., & Nuijts, R. M. M. A. (2018) · Experimental Eye Research · doi:10.1016/j.exer.2018.01.010 · Cited by 92
Optimization by design of etoposide loaded solid lipid nanoparticles for ocular delivery: Characterization, pharmacokinetic and deposition study
Ahmad, I. N., Pandit, J., Sultana, Y., Mishra, A. K., Hazari, P. P., & Aqil, M. (2019) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.03.060 · Cited by 94
Nanomedicine and drug delivery to the retina: current status and implications for gene therapy
Tawfik, M., Chen, F., Goldberg, J. L., & Sabel, B. A. (2022) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-022-02287-3 · Cited by 96
Advances in Biodegradable Nano-Sized Polymer-Based Ocular Drug Delivery
Lynch, C. R., Kondiah, P. P. D., Choonara, Y. E., du Toit, L. C., Ally, N., & Pillay, V. (2019) · Polymers · doi:10.3390/polym11081371 · Cited by 91
Vitreous Humor: Composition, Characteristics and Implication on Intravitreal Drug Delivery
Mishra, D., Gade, S., Glover, K., Sheshala, R., & Singh, T. R. R. (2022) · Current Eye Research · doi:10.1080/02713683.2022.2119254 · Cited by 97
Intravitreal nanoparticles for retinal delivery
Huang, X., & Chau, Y. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.05.005 · Cited by 90
Suprachoroidally injected pharmacological agents for the treatment of chorio‐retinal diseases: a targeted approach
Habot‐Wilner, Z., Noronha, G., & Wykoff, C. C. (2019) · Acta Ophthalmologica · doi:10.1111/aos.14042 · Cited by 87
Designing Covalent Organic Framework‐Based Light‐Driven Microswimmers toward Therapeutic Applications
Sridhar, V., Yıldız, E., Rodríguez‐Camargo, A., Lyu, X., Yao, L., Wrede, P., Aghakhani, A., Akolpoglu, M. B., Podjaski, F., Lotsch, B. V., et al. (2023) · Advanced Materials · doi:10.1002/adma.202301126 · Cited by 83
Nanotechnology for Medical and Surgical Glaucoma Therapy—A Review
Occhiutto, M. L., Maranhão, R. C., Costa, V. P., & Konstas, A. G. P. (2019) · Advances in Therapy · doi:10.1007/s12325-019-01163-6 · Cited by 87
In Vivo Stability of Therapeutic Proteins
Schuster, J., Koulov, A. V., Mahler, H., Detampel, P., Huwyler, J., Singh, S. K., & Mathaes, R. (2020) · Pharmaceutical Research · doi:10.1007/s11095-019-2689-1 · Cited by 81
Local drug delivery systems for inflammatory diseases: Status quo, challenges, and opportunities
Chen, Y.-C., Gad, S. F., Chobisa, D., Li, Y., & Yeo, Y. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.12.025 · Cited by 80
Laser-induced nanobubbles safely ablate vitreous opacities in vivo
Sauvage, F., Nguyen, V. P., Li, Y., Harizaj, A., Sebag, J., Roels, D., Havere, V. V., Peynshaert, K., Xiong, R., Fraire, J. C., et al. (2022) · Nature Nanotechnology · doi:10.1038/s41565-022-01086-4 · Cited by 80
Perspectives of Molecularly Imprinted Polymer-Based Drug Delivery Systems in Cancer Therapy
Bodoki, A., Iacob, B., & Bodoki, E. (2019) · Polymers · doi:10.3390/polym11122085 · Cited by 81
Porous poly(ε-caprolactone) implants: A novel strategy for efficient intraocular drug delivery
Boia, R., Dias, P. A. N., Martins, J., Galindo‐Romero, C., Aires, I. D., Vidal‐Sanz, M., Agudo‐Barriuso, M., de Sousa, H. C., Ambrósio, A. F., Braga, M. E. M., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.09.023 · Cited by 78
Recent Progress of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as Ocular Drug Delivery Platforms
Gugleva, V., & Andonova, V. (2023) · Pharmaceuticals · doi:10.3390/ph16030474 · Cited by 77
Lipid nanoparticles for the posterior eye segment
Bonilla, L., Espina, M., Severino, P., Cano, A., Ettcheto, M., Camins, A., García, M. L., Souto, E. B., & Sánchez-López, E. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics14010090 · Cited by 76
Challenges and innovations of drug delivery in older age
Khan, M. S., & Roberts, M. S. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.09.003 · Cited by 79
In vitro dissolution testing models of ocular implants for posterior segment drug delivery
Adrianto, M. F., Annuryanti, F., WILSON, C. G., Sheshala, R., & Singh, T. R. R. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-01043-z · Cited by 75
Alternative Routes of Administration for Therapeutic Antibodies—State of the Art
Pitiot, A., Heuzé‐Vourc'h, N., & Sécher, T. (2022) · Antibodies · doi:10.3390/antib11030056 · Cited by 80
Emerging Trends in Nanomedicine for Improving Ocular Drug Delivery: Light-Responsive Nanoparticles, Mesoporous Silica Nanoparticles, and Contact Lenses
Rodrigues, F. S. C., Campos, A., Martins, J., Ambrósio, A. F., & Campos, E. J. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c01347 · Cited by 73
A review of nanocarrier-mediated drug delivery systems for posterior segment eye disease: challenges analysis and recent advances
Wang, R., Gao, Y., Liu, A., & Zhai, G. (2021) · Journal of drug targeting · doi:10.1080/1061186x.2021.1878366 · Cited by 73
Prospects for the application of Müller glia and their derivatives in retinal regenerative therapies
Eastlake, K., Lamb, W. D. B., Luis, J., Khaw, P. T., Jayaram, H., & Limb, G. A. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100970 · Cited by 75
Challenges and strategies for ocular posterior diseases therapy via non-invasive advanced drug delivery
Qi, Q., Wei, Y., Zhang, X., Guan, J., & Mao, S. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.07.055 · Cited by 74
Hyaluronic Acid: Its Versatile Use in Ocular Drug Delivery with a Specific Focus on Hyaluronic Acid-Based Polyelectrolyte Complexes
Casey-Power, S., Ryan, R., Behl, G., McLoughlin, P., Byrne, M. E., & Fitzhenry, L. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14071479 · Cited by 75
Selective drug delivery to the retinal cells: Biological barriers and avenues
Ramsay, E., Lajunen, T., Bhattacharya, M., Reinisalo, M., Rilla, K. J., Kidron, H., Terasaki, T., & Urtti, A. O. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.07.028 · Cited by 75
Self-citation
Ocular Pharmacokinetics of Therapeutic Antibodies Given by Intravitreal Injection: Estimation of Retinal Permeabilities Using a 3-Compartment Semi-Mechanistic Model
Hutton-Smith, L. A., Gaffney, E. A., Byrne, H. M., Maini, P. K., Gadkar, K. G., & Mazer, N. A. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00164 · Cited by 71
Repeated Topical Administration of 3 nm Cerium Oxide Nanoparticles Reverts Disease Atrophic Phenotype and Arrests Neovascular Degeneration in AMD Mouse Models
Badia, A. C., Duarri, A., Salas, A., Rosell, J., Ramis, J., Gustà, M. F., Casals, E., Zapata, M. Á., Puntes, V., & García‐Arumí, J. (2023) · ACS Nano · doi:10.1021/acsnano.2c05447 · Cited by 71
Matrix-bound nanovesicles prevent ischemia-induced retinal ganglion cell axon degeneration and death and preserve visual function
van der Merwe, Y., Faust, A. E., Sakalli, E. T., Westrick, C. C., Hussey, G. S., Chan, K. C., Conner, I. P., Fu, V. L. N., Badylak, S. F., & Steketee, M. B. (2019) · Scientific Reports · doi:10.1038/s41598-019-39861-4 · Cited by 74
Bottom‐Up versus Top‐Down Strategies for Morphology Control in Polymer‐Based Biomedical Materials
Cook, A. B., & Clemons, T. D. (2021) · Advanced NanoBiomed Research · doi:10.1002/anbr.202100087 · Cited by 69
Polysaccharide-based hydrogels for drug delivery and wound management: a review
Sanjanwala, D., Londhe, V. Y., Trivedi, R., Bonde, S., Sawarkar, S. P., Kale, V., & Patravale, V. B. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2152791 · Cited by 71
Updates on Biodegradable Formulations for Ocular Drug Delivery
Tsung, T., Chen, Y., & Lu, D. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030734 · Cited by 72
Drug delivery via the suprachoroidal space for the treatment of retinal diseases
Naftali Ben Haim, L., & Moisseiev, E. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13070967 · Cited by 68
Diffusion and Protein Corona Formation of Lipid-Based Nanoparticles in the Vitreous Humor: Profiling and Pharmacokinetic Considerations
Tavakoli, S., Kari, O. K., Turunen, T., Lajunen, T., Schmitt, M., Lehtinen, J., Tasaka, F., Parkkila, P., Ndika, J., Viitala, T., et al. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00411 · Cited by 68
Self-citation
Hyaluronic Acid-PEG-Based Diels–AlderIn SituForming Hydrogels for Sustained Intraocular Delivery of Bevacizumab
Ilochonwu, B. C., Mihajlovic, M., Maas-Bakker, R. F., Rousou, C., Tang, M., Chen, M., Hennink, W. E., & Vermonden, T. (2022) · Biomacromolecules · doi:10.1021/acs.biomac.2c00383 · Cited by 64
Ocular Drug Delivery: A Special Focus on the Thermosensitive Approach
Sapino, S., Chirio, D., Peira, E., Rubio, E. A., Brunella, V., Jadhav, S. A., Chindamo, G., & Gallarate, M. (2019) · Nanomaterials · doi:10.3390/nano9060884 · Cited by 64
Influence of Charge, Hydrophobicity, and Size on Vitreous Pharmacokinetics of Large Molecules
Crowell, S. R., Wang, K., Famili, A., Shatz-Binder, W., Loyet, K. M., Chang, V., Liu, Y., Prabhu, S., Kamath, A. V., & Kelley, R. F. (2019) · Translational Vision Science & Technology · doi:10.1167/tvst.8.6.1 · Cited by 62
Expression, activity and pharmacokinetic impact of ocular transporters
Vellonen, K., Hellinen, L., Mannermaa, E., Ruponen, M., Urtti, A. O., & Kidron, H. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.12.009 · Cited by 64
Self-citation
The effect of light sensitizer localization on the stability of indocyanine green liposomes
Lajunen, T., Nurmi, R., Wilbie, D., Ruoslahti, T., Johansson, N. G., Korhonen, O., Róg, T., Bunker, A., Ruponen, M., & Urtti, A. O. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.06.029 · Cited by 64
Self-citation
Hyaluronic acid-based nanoparticles to deliver drugs to the ocular posterior segment
Jiang, H., & Xu, Z. (2023) · Drug Delivery · doi:10.1080/10717544.2023.2204206 · Cited by 64
Suprachoroidal Injection: A Novel Approach for Targeted Drug Delivery
Wu, K. Y., Fujioka, J. K., Gholamian, T., Zaharia, M., & Tran, S. D. (2023) · Pharmaceuticals · doi:10.3390/ph16091241 · Cited by 67
Impact of Chemical Structure on Conjunctival Drug Permeability: Adopting Porcine Conjunctiva and Cassette Dosing for Construction of In Silico Model
Ramsay, E., Ruponen, M., Picardat, T., Tengvall, U., Tuomainen, M. H., Auriola, S. O. K., Toropainen, E., Urtti, A. O., & del Amo, E. M. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.04.061 · Cited by 62
Self-citation
Colloidal nanosystems with mucoadhesive properties designed for ocular topical delivery
Silva, B., Bráz, B. S., Delgado, E., & Gonçalves, L. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120873 · Cited by 60
Rescue the retina after the ischemic injury by polymer-mediated intracellular superoxide dismutase delivery
Zhou, X., Lv, J., Li, G., Qian, T., Jiang, H., Xu, J., Cheng, Y., & Hong, J. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120600 · Cited by 58
Recent trends in drug-delivery systems for the treatment of diabetic retinopathy and associated fibrosis
Silva, M., Peng, T., Zhao, X., Li, S., Farhan, M., & Zheng, W. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.04.007 · Cited by 58
Stimuli-Responsive Polymers for Transdermal, Transmucosal and Ocular Drug Delivery
Berillo, D. A., Zharkinbekov, Z., Kim, Y., Raziyeva, K., Temirkhanova, K., & Saparov, A. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122050 · Cited by 56
Topical ophthalmic administration: Can a drug instilled onto the ocular surface exert an effect at the back of the eye?
del Amo, E. M. (2022) · Frontiers in Drug Delivery · doi:10.3389/fddev.2022.954771 · Cited by 56
Vesicular Drug Delivery Systems: Promising Approaches in Ocular Drug Delivery
Batur, E., Özdemir, S., Durgun, M. E., & Özsoy, Y. (2024) · Pharmaceuticals · doi:10.3390/ph17040511 · Cited by 60
Advances in Drug Delivery Integrated with Regenerative Medicine: Innovations, Challenges, and Future Frontiers
Rasekh, M., Arshad, M. S., & Ahmad, Z. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17040456 · Cited by 65
Intravitreal implantable magnetic micropump for on-demand VEGFR-targeted drug delivery
Wang, C., Seo, S., Kim, J. S., Lee, S., Jeon, J.-K., Kim, J.-W., Kim, K., Kim, J.-K., & Park, J. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.05.030 · Cited by 56
No flow through the vitreous humor: How strong is the evidence?
Smith, D. W., Lee, C. J., & Gardiner, B. S. (2020) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100845 · Cited by 54
An in vitro Assessment of Thermo-Reversible Gel Formulation Containing Sunitinib Nanoparticles for Neovascular Age-Related Macular Degeneration
Bhatt, P., Narvekar, P., Lalani, R., Chougule, M. B., Pathak, Y. V., & Sutariya, V. B. (2019) · AAPS PharmSciTech · doi:10.1208/s12249-019-1474-0 · Cited by 55
Validation of hyaluronic acid-agar-based hydrogels as vitreous humor mimetics for in vitro drug and particle migration evaluations
Thakur, S. S., Shenoy, S., Suk, J. S., Hanes, J. S., & Rupenthal, I. D. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.01.008 · Cited by 56
Light-Activated Liposomes Coated with Hyaluronic Acid as a Potential Drug Delivery System
Kari, O. K., Tavakoli, S., Parkkila, P., Baan, S., Savolainen, R., Ruoslahti, T., Johansson, N. G., Ndika, J., Alenius, H. T., Viitala, T., et al. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12080763 · Cited by 55
Self-citation
Pharmacokinetic Simulations of Intravitreal Biologicals: Aspects of Drug Delivery to the Posterior and Anterior Segments
Rimpelä, A., Kiiski, I. M. A., Deng, F. Y., Kidron, H., & Urtti, A. O. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics11010009 · Cited by 53
Self-citation
Cyclodextrin–Amphiphilic Copolymer Supramolecular Assemblies for the Ocular Delivery of Natamycin
Lorenzo-Veiga, B., Sigurðsson, H. H., Loftsson, Þ., & Alvarez‐Lorenzo, C. (2019) · Nanomaterials · doi:10.3390/nano9050745 · Cited by 53
Lipid-Based Nanocarriers for Ophthalmic Administration: Towards Experimental Design Implementation
González‐Fernández, F. M., Bianchera, A., Gasco, P., Nicoli, S., & Pescina, S. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13040447 · Cited by 55
Axitinib-Loaded Poly(Lactic-Co-Glycolic Acid) Nanoparticles for Age-Related Macular Degeneration: Formulation Development and In Vitro Characterization
Narvekar, P., Bhatt, P., Fnu, G., & Sutariya, V. B. (2019) · Assay and Drug Development Technologies · doi:10.1089/adt.2019.920 · Cited by 53
Liposomal sunitinib for ocular drug delivery: A potential treatment for choroidal neovascularization
Tavakoli, S., Puranen, J., Bahrpeyma, S., Lautala, V. E., Karumo, S., Lajunen, T., del Amo, E. M., Ruponen, M., & Urtti, A. O. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121725 · Cited by 54
Self-citation
Sub-threshold micropulse laser treatment reduces inflammatory biomarkers in aqueous humour of diabetic patients with macular edema
Midena, E., Micera, A., Frizziero, L., Pilotto, E., Esposito, G., & Bini, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-46515-y · Cited by 51
Ultra-small-size Astragaloside-IV loaded lipid nanocapsules eye drops for the effective management of dry age-related macular degeneration
Sun, R., Zhang, A., Ge, Y. C., Gou, J., Yin, T., He, H., Wang, Y., Zhang, G., Kong, J., Shang, L., et al. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1783236 · Cited by 50
Airborne Fine Particulate Matter (Pm2.5) Damages the Inner Blood–Retinal Barrier by Inducing Inflammation and Ferroptosis in Retinal Vascular Endothelial Cells
Gu, Y., Hao, S., Liu, K., Gao, M., Lu, B., Sheng, F., Zhang, L., Xu, Y., Wu, D., Han, Y., et al. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.156563 · Cited by 50
How can machine learning and multiscale modeling benefit ocular drug development?
Wang, N., Zhang, Y., Wang, W., Ye, Z., Chen, H., Hu, G., & Ouyang, D. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114772 · Cited by 52
Thermo-responsive Diels-Alder stabilized hydrogels for ocular drug delivery of a corticosteroid and an anti-VEGF fab fragment
Ilochonwu, B. C., van der Lugt, S. A., Annala, A., Marco, G. D., Sampon, T., Siepmann, J., Siepmann, F., Hennink, W. E., & Vermonden, T. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.07.052 · Cited by 50
Hyaluronan and its derivatives for ophthalmology: Recent advances and future perspectives
Huerta‐Ángeles, G., & Nešporová, K. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.117697 · Cited by 50

Authors: del Amo, E. M., Rimpelä, A.-K., Heikkinen, E., Kari, O. K., Ramsay, E., Lajunen, T., Schmitt, M., Pelkonen, L., Bhattacharya, M., Richardson, D., Subrizi, A., Turunen, T., Reinisalo, M., Itkonen, J., Toropainen, E., Casteleijn, M., Kidron, H., Antopolsky, M., Vellonen, K.-S., Ruponen, M., & Urtti, A.
Affiliations: University of Helsinki (FI)
University of Eastern Finland (FI)
ORCID: Rimpelä, Anna-Kaisa
Heikkinen, Emma
Kari, Otto K.
Ramsay, Eva
Lajunen, Tatu
Pelkonen, Laura
Bhattacharya, Madhushree
Subrizi, Astrid
Reinisalo, Mika
Itkonen, Jaakko
Toropainen, Elisa
Casteleijn, Marco
Kidron, Heidi
Vellonen, Kati-Sisko
Ruponen, Marika
Urtti, Arto
Venue: Progress in Retinal and Eye Research
Publisher: Elsevier BV
Published: 2017-03
Volume: 57
Pages: 134-185
ISSN: 1350-9462 (ISSN-L)
DOI: 10.1016/j.preteyeres.2016.12.001
OpenAlex: W2567416294
Cited by: 693
References: 476
Citations by year: 2026: 68 · 2025: 96 · 2024: 76 · 2023: 92 · 2022: 74 · 2021: 94 · 2020: 81 · 2019: 59 · 2018: 34 · 2017: 18
FWCI: 3.13
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
Locations: Progress in Retinal and Eye Research (publishedVersion, cc-by-nc-nd)
PubMed (publishedVersion)
Research Explorer (The University of Manchester) (publishedVersion, other-oa)
UEF eRepo (University of Eastern Finland) (submittedVersion)
Työväentutkimus Vuosikirja (submittedVersion)
Funders: Sigrid Juséliuksen Säätiö (64578)
Itä-Suomen Yliopisto
Academy of Finland (263573, 263615, 268868, 272597, 283721)
Tekes (637/31/2015 TEKES)
Seventh Framework Programme
Topics: Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
Keywords: retinal drug delivery, pharmacokinetics, intravitreal injection, systemic drug delivery, topical ocular drug delivery, targeted drug delivery, dosage, tolerability, ocular drug delivery systems
MeSH terms: Animals, Humans, Retina, Retinal Diseases, Tissue Distribution, Drug Delivery Systems, Angiogenesis Inhibitors, Intravitreal Injections

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Pharmacokinetic aspects of retinal drug delivery

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks